A new research perspective was published in Aging (indexed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 22 on December 9, 2024, entitled “Nuclear lipid droplets: a new regulator of nuclear homeostasis and aging.”
In this article, Dr. Konstantinos Palikaras from the National and Kapodistrian University of Athens and Dr. Nektarios Tavernarakis from the University of Crete are investigating how tiny fat droplets, known as nuclear lipid droplets (nLDs), accumulate in the nucleus of cells as we age. . Unlike normal lipid droplets, which store energy in the cytoplasm, these nuclear droplets can weaken the nucleus by disrupting critical cellular processes.
The authors suggest that excessive accumulation of nLDs could lead to nuclear instability and may be linked to metabolic conditions such as fatty liver disease, obesity-related disorders and premature aging. This highlights the potential role of nLDs in cellular senescence and age-related diseases.
Previous research by the authors using Caenorhabditis elegans (C. elegans)a model organism commonly used to study aging, revealed the role of ATGL-1, an enzyme that regulates fat storage in the nucleus. When working properly, ATGL-1 helps maintain a healthy lipid balance. However, when it becomes inactive or overwhelmed, fat droplets accumulate around the nuclear lamina, making it more difficult for the cell to function properly.
“These findings establish excessive nuclear lipid deposition as a key feature of aging, with profound implications for nuclear processes such as chromatin organization, DNA repair, and gene regulation.”
The authors emphasize that lifestyle interventions, such as caloric restriction and better insulin regulation, can significantly reduce the accumulation of harmful nLDs, reinforcing the role of healthy metabolism in slowing cellular aging. They also call for further studies to understand how nLDs behave in human experimental models, particularly in patients with conditions such as metabolic syndrome and progeria. A deeper understanding of these processes could lead to treatments designed to maintain cell health and delay age-related diseases.
In summary, by presenting nuclear lipid droplets as potential therapeutic targets, this research perspective presents a new path for exploring therapies aimed at combating age-related diseases caused by lipid dysregulation.
Source:
Journal Reference:
Palikaras, K & Tavernarakis, N. (2024). Nuclear lipid droplets: a novel regulator of nuclear homeostasis and aging. Aging. doi.org/10.18632/aging.206175.
